Population-based cohort study reveals link between proton pump inhibitor intake and increasing risk for cardiovascular events.
Effect of proton pump inhibitor use on development of cardiovascular diseases
read more
All posts to the category
Population-based cohort study reveals link between proton pump inhibitor intake and increasing risk for cardiovascular events.
New study demonstrates the power of metabolomics in boosting our understanding of fatty liver disease – and possible treatments. Obeticholic acid reverses metabolic changes in NASH.
Metabolites in action: metabolomics reveals link between mitochondrial respiration and proteasomal degradation mechanisms, with important implications for cancer drugs.
The changes in circulating metabolites induced by a multi-AGC kinase inhibitor in mice and patients may contribute to better understand its mechanism of action.
The response of cancer cells to checkpoint inhibition therapy can be predicted using metabolomics.